TNXP financials
Tonix Pharmaceuticals (TNXP) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TNXP income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $13.11M | $6.47M | -$125.70M | -$124.02M | -0.20 |
| 2024 | $10.09M | $2.33M | -$136.70M | -$130.04M | -2.41 |
| 2023 | $7.77M | $3.03M | -$118.38M | -$116.66M | -200.83 |
| 2022 | – | – | -$112.09M | -$116.88M | -586.96 |
| 2021 | – | – | -$92.31M | -$92.29M | -1449.78 |
| 2020 | – | – | -$50.51M | -$52.17M | -319.25 |
- TNXP revenue was $13.11M in fiscal 2025, net income -$124.02M.
Updated 2026-11-12 15:54 UTC